Akshay Gupte, PhD, MBBS, MSPH
Assistant Professor
Boston University School of Public Health
Global Health

MD, Maharashtra University of Health Science
PhD, Johns Hopkins University School of Public Health
MSPH, Johns Hopkins University School of Public Health
BA, Maharashtra University of Health Science



Dr. Gupte is a physician-scientist whose research is focused on the intersection of infectious and chronic lung diseases in low- and middle-income settings. He leads several Indo-US collaborative studies to describe the epidemiology and pathogenesis of lung injury in tuberculosis (TB)/HIV/diabetes, measure its impact on poor clinical outcomes, and identify therapeutic and programmatic interventions to improve post-TB lung health and longevity.

Dr. Gupte serves on several multi-national TB/HIV research consortia, such as the TB Transformative Science Working Group of the AIDS Clinical Trials Group (ACTG), Lung Health Working Group of the International Epidemiology Databases to Evaluate AIDS (IeDEA) network, and is Chairperson of the Clinical and Epidemiology Working Group of the RePORT-India TB Research Consortium.

Dr. Gupte completed his medical training in India, Master’s and Doctoral training from the Johns Hopkins Bloomberg School of Public Health, and has previously served as faculty in the Division of Infectious Diseases, Johns Hopkins School of Medicine. He is a 2017 Fogarty Fellow and recipient of the Arthur M. Dannenberg, Jr., Award for excellence in TB research.


TB Aftermath
06/01/2022 - 05/31/2025 (Subcontract PI)
Johns Hopkins University NIH NIAID
5R01AI143748-03

Phenotype, Progression and Immune Correlates of Post-Tuberculosis Lung Disease
04/05/2023 - 03/31/2025 (PI)
NIH/National Institute of Allergy & Infectious Diseases
4R00AI151094-03



Title

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Queiroz ATL, Vinhaes CL, Fukutani ER, Gupte AN, Kumar NP, Fukutani KF, Arriaga MB, Sterling TR, Babu S, Gaikwad S, Karyakarte R, Mave V, Paradhkar M, Viswanathan V, Gupta A, Andrade BB, Kornfeld H. A multi-center, prospective cohort study of whole blood gene expression in the tuberculosis-diabetes interaction. Sci Rep. 2023 May 12; 13(1):7769. PMID: 37173394; PMCID: PMC10180618; DOI: 10.1038/s41598-023-34847-9;
     
  2. Sinha P, Ponnuraja C, Gupte N, Prakash Babu S, Cox SR, Sarkar S, Mave V, Paradkar M, Cintron C, Govindarajan S, Kinikar A, Priya N, Gaikwad S, Thangakunam B, Devarajan A, Dhanasekaran M, Tornheim JA, Gupta A, Salgame P, Christopher DJ, Kornfeld H, Viswanathan V, Ellner JJ, Horsburgh CR, Gupte AN, Padmapriyadarsini C, Hochberg NS. Impact of Undernutrition on Tuberculosis Treatment Outcomes in India: A Multicenter, Prospective, Cohort Analysis. Clin Infect Dis. 2023 Apr 17; 76(8):1483-1491.View Related Profiles. PMID: 36424864; PMCID: PMC10319769; DOI: 10.1093/cid/ciac915;
     
  3. Cox SR, Padmapriyadarsini C, Mave V, Seth B, Thiruvengadam K, Gaikwad S, Sahasrabudhe TR, Sane M, Tornheim JA, Shrinivasa BM, Lokhande R, Barthwal MS, Shivakumar SVBY, Krishnan S, Santhappan R, Kinikar A, Kakrani AL, Paradkar M, Bollinger RC, Sekar K, Gupte AN, Hanna LE, Gupta A, Golub JE. Characterising cause of death among people treated for drug-susceptible TB in India. Int J Tuberc Lung Dis. 2023 Jan 01; 27(1):78-80. PMID: 36853129
     
  4. Deshmukh S, Sane M, Gaikwad S, Sahasrabudhe T, Barthwal M, Lokhande R, Raskar S, Kagal A, Dharmshale S, Pradhan N, Gupte A, Alfarisi O, Gupta A, Dooley KE, Gupte N, Golub JE, Mave V. Sex Differences in TB Clinical Presentation, Drug Exposure, and Treatment Outcomes in India. Chest. 2023 Apr; 163(4):778-789. PMID: 36174745; PMCID: PMC10258435; DOI: 10.1016/j.chest.2022.09.024;
     
  5. Cox SR, Kadam A, Atre S, Gupte AN, Sohn H, Gupte N, Sawant T, Mhadeshwar V, Thompson R, Kendall E, Hoffmann C, Suryavanshi N, Kerrigan D, Tripathy S, Kakrani A, Barthwal MS, Mave V, Golub JE. Tuberculosis (TB) Aftermath: study protocol for a hybrid type I effectiveness-implementation non-inferiority randomized trial in India comparing two active case finding (ACF) strategies among individuals treated for TB and their household contacts. Trials. 2022 Aug 05; 23(1):635. PMID: 35932062; PMCID: PMC9354295; DOI: 10.1186/s13063-022-06503-6;
     
  6. Baidya A, Sangle S, Marbaniang I, Kulkarni V, Deshpande P, Nimkar S, Chavan A, Salvi S, Lokhande R, Kadam D, Gupta A, Mave V, Gupte AN. Clinical and Immunological Markers of Pulmonary Impairment Among People With HIV in India. Open Forum Infect Dis. 2022 Jul; 9(7):ofac233. PMID: 35836747; PMCID: PMC9274441; DOI: 10.1093/ofid/ofac233;
     
  7. Gupte AN, Kumar P, Araújo-Pereira M, Kulkarni V, Paradkar M, Pradhan N, Menon P, Padmapriyadarsini C, Hanna LE, Yogendra Shivakumar SVB, Rockwood N, Du Bruyn E, Karyakarte R, Gaikwad S, Bollinger R, Golub J, Gupte N, Viswanathan V, Wilkinson RJ, Mave V, Babu S, Kornfeld H, Andrade BB, Gupta A. Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation study. Eur Respir J. 2022 04; 59(4). PMID: 34711538; PMCID: PMC7612881; DOI: 10.1183/13993003.00905-2021;
     
  8. Shivakoti R, Newman JW, Hanna LE, Queiroz ATL, Borkowski K, Gupte AN, Paradkar M, Satyamurthi P, Kulkarni V, Selva M, Pradhan N, Shivakumar SVBY, Natarajan S, Karunaianantham R, Gupte N, Thiruvengadam K, Fiehn O, Bharadwaj R, Kagal A, Gaikwad S, Sangle S, Golub JE, Andrade BB, Mave V, Gupta A, Padmapriyadarsini C. Host lipidome and tuberculosis treatment failure. Eur Respir J. 2022 01; 59(1). PMID: 34375300; PMCID: PMC9625841; DOI: 10.1183/13993003.04532-2020;
     
  9. Tornheim JA, Udwadia ZF, Arora PR, Gajjar I, Sharma S, Karane M, Sawant N, Kharat N, Blum AJ, Shivakumar SVBY, Gupte AN, Gupte N, Mullerpattan JB, Pinto LM, Ashavaid TF, Gupta A, Rodrigues C. Increased Moxifloxacin Dosing Among Patients With Multidrug-Resistant Tuberculosis With Low-Level Resistance to Moxifloxacin Did Not Improve Treatment Outcomes in a Tertiary Care Center in Mumbai, India. Open Forum Infect Dis. 2022 Feb; 9(2):ofab615. PMID: 35097152; PMCID: PMC8794589; DOI: 10.1093/ofid/ofab615;
     
  10. Kamenar K, Hossen S, Gupte AN, Siddharthan T, Pollard S, Chowdhury M, Rubinstein AL, Irazola VE, Gutierrez L, Miranda JJ, Bernabe-Ortiz A, Alam D, Kirenga B, Jones RC, van Gemert F, Wise RA, Checkley W. Previous tuberculosis disease as a risk factor for chronic obstructive pulmonary disease: a cross-sectional analysis of multicountry, population-based studies. Thorax. 2022 Nov; 77(11):1088-1097. PMID: 34853154
     
Showing 10 of 40 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 40 publications over 8 distinct years, with a maximum of 10 publications in 2019

YearPublications
20162
20171
20182
201910
20208
20219
20225
20233


2018 Fogarty International Center, NIH: Fogarty Global Health Fellowship
2017 Johns Hopkins School of Medicine: Arthur M. Dannenberg Jr. Award for Tuberculosis Research
2016 Conference on Retroviruses and Opportunistic Infections: CROI Young Investigator Award
2014 Johns Hopkins School of Medicine: Ujala Scholar
Contact for Mentoring:

801 Massachusetts Ave
Boston MA 02118
Google Map


Gupte's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department